Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Systemic effects in COPD.

Emil F M Wouters1, Eva C Creutzberg, Annemie M W J Schols

  • 1Department of Pulmonary Diseases, University Hospital Maastricht, PO Box 5800, 6202 AZ Maastricht, the Netherlands. ewo@ms-azm-3.azm.nl

Chest
|May 16, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-term multidimensional health status of individuals with and without post COVID-19 condition: A cross-sectional study.

PloS one·2026
Same author

Real-World Data on the Use of Follitropin Delta in a Dutch IVF Center.

Reproductive medicine and biology·2026
Same author

Beyond the lungs: The role of extrapulmonary manifestations in the quality of life of Indians with chronic airway diseases.

Respiratory medicine·2026
Same author

Changes in computed tomography derived muscle and pulmonary tissue in patients hospitalized for COVID-19: A 12-month follow-up study.

Clinical nutrition ESPEN·2026
Same author

Assessing Lifestyle Goal Setting in Patients with COPD.

International journal of chronic obstructive pulmonary disease·2026
Same author

Glucocorticoid-induced muscle weakness in ECOPD: a perspective on mechanisms and emerging pharmacological interventions.

Expert review of respiratory medicine·2026

Chronic obstructive pulmonary disease (COPD) involves systemic inflammation, oxidative stress, and muscle wasting. Targeting inflammatory pathways may improve prognosis and quality of life for COPD patients.

Area of Science:

  • Pulmonary Medicine
  • Biochemistry
  • Cellular Biology

Background:

  • COPD pathogenesis extends beyond lung inflammation to systemic effects.
  • Systemic alterations include oxidative stress, altered inflammatory mediators, and acute-phase proteins.
  • Patients with COPD often exhibit weight loss, muscle wasting, and reduced exercise capacity.

Purpose of the Study:

  • To review the systemic manifestations of COPD.
  • To discuss the mechanisms of weight loss and muscle wasting in COPD.
  • To explore potential therapeutic strategies targeting systemic inflammation and cachexia.

Main Methods:

  • Literature review of studies on COPD pathogenesis and systemic effects.
  • Analysis of biochemical and hormonal alterations in COPD patients.

Related Experiment Videos

  • Discussion of cytokine involvement in muscle protein metabolism.

    • Main Results:

    • COPD is characterized by systemic oxidative stress and inflammation.
    • Impaired oxidant-antioxidant balance and altered cytokine levels are observed.
    • Weight loss and muscle wasting are significant clinical features linked to poor prognosis.

    Conclusions:

    • Systemic inflammation and hormonal imbalances contribute to muscle wasting in COPD.
    • Inhibiting cytokine signaling may offer a therapeutic approach.
    • Reducing muscle wasting and cachexia could improve COPD patient outcomes and quality of life.